Emerging Weapons Against Generics Competition
Since enactment of the Hatch-Waxman Act in 1984, the U.S. Food and Drug Administration has been at the vortex of pharmaceutical patent enforcement....To view the full article, register now.
Already a subscriber? Click here to view full article